MwanzoNZYMB • SWX
Novozymes A/S
CHF 44.68
30 Jan, 22:05:00 GMT +1 · CHF · SWX · Kanusho
HisaNembo ya GLeafInaongoza katika utunzaji wa mazingiraHisa zinazouzwa CH
Bei iliyotangulia
CHF 44.68
Bei za mwaka
CHF 44.68 - CHF 44.68
Thamani ya kampuni katika soko
169.71B DKK
Uwiano wa bei na mapato
-
Mgao wa faida
-
Ubadilishanaji wa msingi
CPH
Alama ya CDP ya Tabia Nchi
A
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
(EUR)Jun 2024Mabadiliko Tangu Mwaka Uliopita
Mapato
915.85M61.70%
Matumizi ya uendeshaji wa biashara
271.75M52.62%
Mapato halisi
31.95M-60.72%
Kiwango cha faida halisi
3.49-75.70%
Mapato kwa kila hisa
EBITDA
150.94M-16.50%
Asilimia ya kodi ya mapato
29.00%
Jumla ya mali
Jumla ya dhima
(EUR)Jun 2024Mabadiliko Tangu Mwaka Uliopita
Uwekezaji wa pesa taslimu na vipindi vifupi
260.80M85.35%
Jumla ya mali
15.25B302.43%
Jumla ya dhima
4.25B119.23%
Jumla ya hisa
11.00B
hisa zilizosalia
277.90M
Uwiano wa bei na thamani
1.13
Faida inayotokana na mali
1.83%
Faida inayotokana mtaji
2.15%
Mabadiliko halisi ya pesa taslimu
(EUR)Jun 2024Mabadiliko Tangu Mwaka Uliopita
Mapato halisi
31.95M-60.72%
Pesa kutokana na shughuli
264.05M74.01%
Pesa kutokana na uwekezaji
-27.45M70.98%
Pesa kutokana na ufadhili
-186.70M-205.10%
Mabadiliko halisi ya pesa taslimu
55.55M902.56%
Mtiririko huru wa pesa
-17.57M68.87%
Kuhusu
Novozymes A/S was a global biotechnology company headquartered in Bagsværd, outside of Copenhagen, Denmark. The company's focus was the research, development and production of industrial enzymes, microorganisms, and biopharmaceutical ingredients. The company merged with Chr. Hansen to form Novonesis in January 2024. Prior to the merger, the company had operations around the world, including in China, India, Brazil, Argentina, United Kingdom, the United States, and Canada. Class B shares of its stock were listed on the NASDAQ OMX Nordic exchange. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
2000
Wafanyakazi
10,452
Tafuta
Futa utafutaji
Funga kisanduku cha kutafutia
Programu za Google
Menyu kuu